Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 4INDUSTRY 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Chemotherapy Induced Neutropenia 2Prostatic Neoplasms 1Lymphoma 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × pegylated granulocyte colony-stimulating factor, human × Clear all
NCT02963389 2019-01-15

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

Dong-A ST Co., Ltd.

Phase 1 Completed
27 enrolled
Lymphoid

Lymphoma

NCT02441894 2017-01-24

PEGAZUS

Sanofi

Phase 4 Completed
21 enrolled
Genitourinary

Prostatic Neoplasms

NCT01674855 2014-10-01

PEG-G-CSF

Dong-A ST Co., Ltd.

Phase 3 Completed
74 enrolled

Chemotherapy Induced Neutropenia

NCT01923545 2014-10-01

PEG-G-CSF

Dong-A ST Co., Ltd.

Phase 2 Completed
61 enrolled

Chemotherapy Induced Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡